Shares outstanding increased 25.9%
Shares outstanding changed +25.9% from the comparable as-filed period. The change ranks at the 100th percentile of 7 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +25.9% from the comparable as-filed period. The change ranks at the 100th percentile of 7 prior comparable changes.
Current liabilities changed +41.2% from the comparable as-filed period.
Inventory changed +52.8% from the comparable as-filed period.
Current assets changed +74.2% from the comparable as-filed period.
Cash & equivalents changed +78.9% from the comparable as-filed period.
Net debt changed -43.7% from the comparable as-filed period.
Working capital changed +96.6% from the comparable as-filed period.
Capex / revenue changed +858 basis points from the comparable as-filed period.
Revenue changed +20.5% from the comparable as-filed period.
Inventory / revenue changed +2489 basis points from the comparable as-filed period.
Capital expenditure changed +159.1% from the comparable as-filed period.
Free-cash-flow proxy changed -849.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Total assets changed +19.7% from the comparable as-filed period.
Current long-term debt changed +93.1% from the comparable as-filed period.
Debt / assets changed -736 basis points from the comparable as-filed period.
Operating cash flow changed -157.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Research & development changed +23.4% from the comparable as-filed period.
Cash / debt changed +2601 basis points from the comparable as-filed period.
Working capital / assets changed +981 basis points from the comparable as-filed period.
Noncurrent long-term debt changed -14.6% from the comparable as-filed period.
Gross debt changed -14.4% from the comparable as-filed period.
Reported total debt changed -14.4% from the comparable as-filed period.
Trade receivables changed +17.6% from the comparable as-filed period.
Current ratio changed +23.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / revenue changed -7226 basis points from the comparable as-filed period.
Free-cash-flow margin changed -2465 basis points from the comparable as-filed period.
Operating cash-flow margin changed -1607 basis points from the comparable as-filed period.
Stock-based compensation changed +25.9% from the comparable as-filed period.
Selling, general & administrative changed +15.6% from the comparable as-filed period.
Receivables / revenue changed -164 basis points from the comparable as-filed period.
SBC / revenue changed +12 basis points from the comparable as-filed period.
R&D / revenue changed +24 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.